Leukemia, 2014-04, Vol.28 (4), p.967-970
2014
Details
- Autor(en) / Beteiligte
- Titel
- Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients
- Ist Teil von
- Leukemia, 2014-04, Vol.28 (4), p.967-970
- Ort / Verlag
- England: Nature Publishing Group
- Erscheinungsjahr
- 2014
- Link zum Volltext
- Quelle
- Nexis
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0887-6924eISSN: 1476-5551DOI: 10.1038/leu.2014.31Titel-ID: cdi_proquest_miscellaneous_1524397515
- Format
- –
- Schlagworte
- Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols - therapeutic use, Bone marrow, Chemotherapy, Cytarabine, Cytarabine - administration & dosage, Dosage and administration, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Hematology, Humans, Letters to the editor, Leukemia, Leukemia research, Leukemia, Myeloid, Acute - drug therapy, Leukemia, Myeloid, Acute - genetics, Medical prognosis, Mortality, Oncology, Prospective Studies, Remission (Medicine), Remission Induction, Thalidomide - administration & dosage, Thalidomide - analogs & derivatives, Toxicity